Pav
Life Science Industry Hub Smart Service Centre
R&D and Virology Centre
Large-Scale Microbial Production Centre
Large-Scale Mammalian Production Centre
Stem Cell Research and 3D Bioprinting Centre
Gene Therapy Centre
Discover BIO CITY
The BIO CITY is a hub of biotechnologies, where cutting-edge tech meets boundless ideas to shape the future and redefine what’s possible. Here, science, technology and creativity converge to fuel a shared mission – a future where we will live longer, healthier and more fulfilled lives. When we talk about the future, we don’t just see challenges – we see endless opportunities. Because throughout time, the most precious asset will remain forever unchanged – life itself.
Welcome to BIO CITY
Welcome to the hub of alive technologies
BIO CITY Guide
- An area equivalent to 10 soccer fields
- Over 7 billion euros of investments over a period of 10 years
- 4 cutting-edge cGMP production facilities
- 2 state-of-the-art research centres
- Creating 2,100 new jobs
Showcase
BIO CITY is poised to launch the premier Gene Therapy Centre in the Baltic States, dedicated to contract development and the manufacturing of gene therapies. Catering to an estimated 280 million individuals globally who are facing rare genetic diseases, our state-of-the-art facility will focus on both advanced research and the production of solutions. By establishing this centre, we aim to introduce 100 specialised roles in the CDMO sector. This initiative underscores our commitment to be leaders of the industry and to actualise a transformative vision.
The R&D and Virology Centre at BIO CITY is exclusively devoted to the advancement of gene therapy research. As an integral part of our CDMO services, this centre will harness cutting-edge technologies and methodologies, to pioneer innovative solutions in the gene therapy domain. Our commitment is to bridge the gap between complex research and practical applications, providing our partners with unparalleled expertise and capabilities in gene therapy development.
Our Life Science Industry Hub will serve as a beacon for integrating intelligent solutions into biotechnological research. The aim of the hub is to foster a collaborative environment where innovation, technology and life sciences intersect, ensuring that research is not only cutting-edge but also accessible and transformative for the industry as a whole.
Specialising in contract development and the manufacturing of stem cell therapies, the Stem Cell and 3D Bioprinting Centre promises to be a beacon of innovation. The facility will offer specialised services for the identification, characterisation and expansion of isolated primary stem cell populations. With our cutting-edge automated bioreactor systems, we aim to provide therapeutic applications, thereby reinforcing our commitment to excellence in the industry.
BIO CITY’s Large-Scale Microbial Production Centre is the epitome of excellence in the contract manufacturing of microbial proteins. Designed to meet the rigorous demands of the industry, the facility will be equipped with advanced tools, including Stainless Steel Bioreactors and Industrial Chromatographic systems, to ensure an unparalleled product quality and compliance with the standards.
Our Large-Scale Mammalian Production Centre signifies a leap forward in the CDMO sector’s approach to the contract development and manufacturing of therapeutic monoclonal antibodies. With a focus on diseases like cancer, asthma and other inflammatory conditions, the facility will harness the most sophisticated technologies, ensuring optimal protein purification and manufacturing.
Timeline
1
Gene Therapy Centre
2024
3
Life Science Industry Hub Smart Service Centre
2027
2
R&D and Virology Centre
2026
4
Stem Cell Research and 3D Bioprinting Centre
2028
5
Large-Scale Microbial Production Centre
2029
6
Large-Scale Mammalian Production Centre
2030
1
Gene Therapy Centre
2024
2
R&D and Virology Centre
2026
3
Life Science Industry Hub Smart Service Centre
2027
4
Stem Cell Research and 3D Bioprinting Centre
2028
5
Large-Scale Microbial Production Centre
2029
6
Large-Scale Mammalian Production Centre
2030
Contact Us
